Related Experiment Video

Updated: Jul 3, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis

Sven Perner, Mark A Rubin

    Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
    |July 26, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
    08:30

    MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

    Published on: May 16, 2012

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    Related Experiment Videos

    Last Updated: Jul 3, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
    08:30

    MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

    Published on: May 16, 2012

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    Related Concept Videos

    RNA Splicing01:32

    RNA Splicing

    Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

    Articles linked to this work by shared authors, journal, and citation graph.

    LRRC8A as a candidate biomarker of cisplatin sensitivity in muscle-invasive bladder cancer: an exploratory immunohistochemical study.

    International urology and nephrology·2026

    Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.

    NPJ precision oncology·2026

    The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.

    Clinical genetics·2026

    A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

    The Journal of experimental medicine·2026

    Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate Cancer.

    Cancer research·2026

    A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

    Cancer research·2026

    sWGS Identifies a Copy-Number-High Subset of TP53-mutated Multiple-Classifier Endometrial Carcinomas With Adverse Clinicopathological Features.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Disentangling the cellular composition of FLCN-mutated tumors in Birt-Hogg-Dubé Syndrome by spatial transcriptomics.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Clinicopathological and Molecular Insights into ERBB2-altered S100/SOX10-positive Uterine Sarcoma: A Report of 6 Cases.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Acute Myeloid Leukemia With KMT2A Amplification: A TP53-Alteration-Enriched Subgroup Associated With Chromoanagenesis and Poor Prognosis.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Histopathologic, Genomic, and Clinical Characteristics of Primary Cutaneous Melanocytic Tumors With Concomitant NRAS Q61 and IDH1 R132C Mutations.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

    Transforming therapeutics through biomaterials: A comprehensive insight into biomaterials' role in effective drug delivery and healthcare advancement.

    Biomaterials translational·2026

    Modifiable Transdiagnostic Risk and Protective Factors as Potential CBT Augmentation Targets for Eating Disorders: An Updated Umbrella Review.

    The International journal of eating disorders·2026

    Long-Term Survival of Patients Undergoing Transcatheter Aortic Valve Implantation Under General Anesthesia Versus Monitored Anesthesia Care.

    Journal of cardiothoracic and vascular anesthesia·2026

    Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data.

    Therapie·2026

    Synthesis and characterization of l-arginine-grafted chitosan nanoparticles for intranasal Dasatinib delivery and brain targeting.

    Nanomedicine : nanotechnology, biology, and medicine·2026

    Piceatannol loaded mesenchymal stem cells derived exosomes for cutaneous regenerative treatment of psoriasis-like symptoms in imiquimod-induced mice model: Exosomal hydrogel impact via targeting of JAK3/STAT3 signaling.

    Nanomedicine : nanotechnology, biology, and medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us